Weight Loss/General Basic Wellness Labs
GLP1-RA medications such as Semaglutide or Tirzepatide are medications used to treat type 2 diabetes, and they work by stimulating insulin release and reducing glucose production in the liver. As with any medication, it is important for healthcare providers to monitor patients taking GLP1-RAs to ensure they are being used safely and effectively.
Lab recommendations for patients taking GLP1-RAs typically include regular monitoring of blood glucose levels and hemoglobin A1c (HbA1c), a measure of average blood glucose levels over the past 2-3 months. Patients should also have their kidney function tested periodically, as GLP1-RAs can affect kidney function in some cases.
In addition to these standard lab tests, healthcare providers may also recommend monitoring of certain electrolytes, such as potassium and magnesium, as well as liver function tests. This is because GLP1-RAs can affect electrolyte balance and liver enzymes in some patients.
Patients taking GLP1-RAs may also be advised to monitor their blood pressure and lipid levels, as these can be affected by diabetes and may be further impacted by the medication.
Overall, the specific lab recommendations for patients taking GLP1-RAs will depend on their individual health status and any other medications they may be taking. Healthcare providers will work with each patient to develop an individualized monitoring plan to ensure the medication is being used safely and effectively.
Venipuncture (discounted) Free with weight loss program plan
Provider lab consultation and treatment plan $ Free with weight loss program plan
(C917) CBC without differential
(C145) Hemoglobin AIC
(C906) Lipid Panel